Spatiotemporal control of engineered bacteria to express interferon-γ by focused ultrasound for tumor immunotherapy

• Published in: Nature communications Vol. 13; no. 1; p. 4468
• Main Authors: Chen, Yuhao, Du, Meng, Yuan, Zhen, Chen, Zhiyi, Yan, Fei
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 02.08.2022; Nature Publishing Group; Nature Portfolio
• Subjects: 13/1; 13/21; 13/31; 13/44; 13/51; 14/19; 14/34; 14/63; 38/35; 631/250/251/1567; 631/61/2297; 692/4028/67/1059; Anticancer properties; Bacteria; Bacteria - metabolism; Cancer immunotherapy; Controlled release; Cytokines; Engineers; Gene expression; Genes; Humanities and Social Sciences; Humans; Hyperthermia; Immune response; Immunotherapy; Immunotherapy - methods; In vivo methods and tests; Interferon; Interferon-gamma - genetics; Interferon-gamma - metabolism; multidisciplinary; Neoplasms - genetics; Neoplasms - therapy; Remote control; Science; Science (multidisciplinary); Tumors; Ultrasonic imaging; Ultrasound; γ-Interferon
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-022-31932-x

Bacteria-based tumor therapy has recently attracted wide attentions due to its unique capability in targeting tumors and preferentially colonizing the core area of the tumor. Various therapeutic genes are also harbored into these engineering bacteria to enhance their anti-tumor efficacy. However, it is difficult to spatiotemporally control the expression of these inserted genes in the tumor site. Here, we engineer an ultrasound-responsive bacterium (URB) which can induce the expression of exogenous genes in an ultrasound-controllable manner. Owing to the advantage of ultrasound in tissue penetration, an acoustic remote control of bacterial gene expression can be realized by designing a temperature-actuated genetic switch. Cytokine interferon-γ (IFN-γ), an important immune regulatory molecule that plays a significant role in tumor immunotherapy, is used to test the system. Our results show that brief hyperthermia induced by focused ultrasound promotes the expression of IFN-γ gene, improving anti-tumor efficacy of URB in vitro and in vivo. Our study provides an alternative strategy for bacteria-mediated tumor immunotherapy. Several approaches have been recently proposed to engineer bacteria for cancer immunotherapy. Here the authors design an ultrasound-responsive bacterium for the controlled release of IFNy at the tumor site, promoting anti-tumor immune responses in preclinical models.